biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BiOasis Vs Annexon!

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Sep 16, 2022 9:31am

150 Views

Post# 34966552

RE:BiOasis Vs Annexon!

Sept.14th blurb,,,,!

Annexon, Inc. (NASDAQ:ANNX – Get Rating) has been given an average recommendation of “Buy” by the six brokerages that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued a report on the stock in the last year is $26.00.

Market Cap at that point would be $1.7 Billion!!!! Yummmmie!!!

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1